Sunakawa, Y., Stintzing, S., Cao, S., Luecke, J., Thompson, D., Moran, M., Astrow, S. H., Hsiang, J., Stephens, C., Zhang, W., Tsuji, A., Takahashi, T., Denda, T., Shimada, K., Kochi, M., Takeuchi, M., Fujii, M., Ichikawa, W., Heinemann, V., & Lenz, H. (n.d.). 483PA biomarker study to validate predictors for clinical outcome of cetuximab based chemotherapy in first-line metastatic colorectal cancer (mCRC) patients: JACCRO CC-05/06AR and FIRE-3. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095481969.0x000035